Kiniksa Pharmaceuticals International (KNSA) Interest Coverage Ratio (QoQ) (2018 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Interest Coverage Ratio (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 4.82 Bn | 4.36 Bn | 193.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.78% |
| Dec 31, 2025 | 805.24% |
| Sep 30, 2025 | 181.63% |
| Jun 30, 2025 | -82.47% |
| Mar 31, 2025 | 1,429,011.43% |
| Dec 31, 2024 | 99.99% |
| Sep 30, 2024 | -32,918.80% |
| Dec 31, 2023 | 100.04% |
| Sep 30, 2023 | -1,755.62% |
| Dec 31, 2021 | 86.88% |
| Sep 30, 2021 | 24.38% |
| Jun 30, 2021 | 17.71% |
| Mar 31, 2021 | 39.15% |
| Dec 31, 2020 | 79.05% |
| Sep 30, 2020 | -60.34% |
| Jun 30, 2020 | -211.49% |
| Mar 31, 2020 | 94.50% |
| Dec 31, 2019 | -934.78% |
| Sep 30, 2019 | 94.05% |
| Jun 30, 2019 | -130.42% |